UK stocks finish higher as banks, AstraZeneca climb
AstraZeneca rises on late-stage drug trial successUK GDP eyed later in the weekFTSE 100 up 0.9%, FTSE 250 adds 0.2%March...
archiveSHRACT
Morning Bid: Bank angst persists, unnerves Europe
A look at the day ahead in U.S. and global markets from Mike DolanAfter a week of sweeping interest rate...
Morning Bid: Inflation ‘blip’ or brave new world?
A look at the day ahead in U.S. and global markets from Mike DolanThere was a sense of hesitation in...
Morning Bid: Blue chips cheered up
A look at the day ahead in U.S. and global markets from Mike DolanFor markets increasingly wary of the inflation...
Morning Bid: Corporate scatter | Reuters
A look at the day ahead in U.S. and global markets from Mike Dolan.A hail of mega corporate updates distracted...
Morning Bid: Japan hesitates | Reuters
A look at the day ahead in U.S. and global markets from Mike Dolan.Judging by Wednesday's reaction, world markets reckon...
Morning Bid: Money in the bank
A look at the day ahead in U.S. and global markets from Mike Dolan.Flush with relief that U.S. inflation is...
Wall St up as Goldman results keep optimism alive, rising yields cap gains
Goldman Sachs benefits from higher interest ratesMicrosoft rises on report of job cutsIndexes up: Dow 0.89%, S&P 0.96%, Nasdaq 0.90%Oct...
Wall Street rallies after BofA results, UK reversal
Bank of America, BNY benefit from rising interest ratesGrowth stocks jump as Treasury yields fallGoldman Sachs up on report of...
